RxDoctor Payments Data

Mekenzie Cooper, APRN

Psychiatric/Mental Health · Orem, UTNPI 1861701344

Payments from drug & device makers

$731in general payments, 2019–2025

Across 42 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$226
  • Lundbeck LLC$125
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
  • Otsuka America Pharmaceutical, Inc.$54
  • Tris Pharma Inc$48
  • Axsome Therapeutics, Inc.$44
  • plus $153 from 6 others

What the payments were for

  • Food & beverage$68494%
  • Education$476%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$731 in reported general payments places this provider in the 55th percentile of 393 psychiatric/mental health providers in Utah.

See all psychiatric/mental health providers in Utah

Medicare billing

Part B allowed, 2024
$7,495
Medicare patients
15
Services billed
111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl12$20,116
Lisdexamfetamine Dimesylate27$6,625
Bupropion XlBupropion Hcl53$1,735
Desvenlafaxine Succinate ErDesvenlafaxine Succinate18$1,722
Gabapentin43$1,618
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine29$1,488
Clonazepam94$1,329
Quetiapine Fumarate41$1,163
Lamotrigine46$1,138
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine36$1,001
Olanzapine OdtOlanzapine14$768
Escitalopram Oxalate45$677
Trazodone Hcl31$590
Alprazolam37$536
Sertraline Hcl16$456

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$226$20,11612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 393 psychiatric/mental health providers in Utah.

Other psychiatric/mental health in Orem

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →